Disease/Infection News

RSS

Gilead Sciences to present results from four Phase 3 clinical trials at International Liver Congress 2013

Gilead Sciences, Inc. today announced that detailed results from four Phase 3 clinical trials (NEUTRINO, FISSION, POSITRON and FUSION) evaluating sofosbuvir, the company's investigational once-daily nucleotide NS5B inhibitor for the treatment of chronic hepatitis C virus infection, will be presented this week in oral sessions at the 48th Annual Meeting of the European Association for the Study of the Liver in Amsterdam, The Netherlands.

23 Apr 2013

GeneCapture developing new device with one-hour pathogen testing capabilities

A company hatched as a partnership between The University of Alabama in Huntsville and chemical engineering professor Dr. Krishnan Chittur is in the design phase for a device that can provide physicians one-hour pathogen testing capabilities.

23 Apr 2013

U.S. Supreme Court to hear oral arguments to decide fate of anti-prostitution pledge

"On Monday, the Supreme Court hears oral arguments in a case that will decide if recipients of government aid can be forced to oppose prostitution -- or potentially any other issue as a contingency of receiving U.S. funds," The Nation reports.

23 Apr 2013

Highly active ART does not appear to impair heart function, study suggests

Long-term use of highly active antiretroviral therapies does not appear to be associated with impaired heart function in children and adolescents in a study that sought to determine the cardiac effects of prolonged exposure to HAART on children infected with the human immunodeficiency virus, according to a report published Online First by JAMA Pediatrics, a JAMA Network publication.

23 Apr 2013

Partnership and accountability among countries will lead to global health successes

In remarks at the Africa Health Forum on Friday in Washington, D.C., Deputy Secretary of State William Burns discussed the evolution of foreign assistance and cooperation "from a donor-recipient relationship to more of a partnership," according to a speech transcript provided by the U.S. State Department.

23 Apr 2013

Number of H7N9 cases surpasses 100; U.S. CDC warns physicians to be vigilant

"The number of bird flu cases in China jumped Sunday to 102, including 20 deaths, the World Health Organization announced," CNN reports, noting 70 patients remain hospitalized with the new H7N9 avian flu strain and the "WHO said there is still no evidence of human-to-human transmission" (Gray/Armstrong, 4/22).

23 Apr 2013

U.S. leaders, AIDS activists gather in Washington to discuss 'shared responsibility' in tackling disease

An article on the UNAIDS webpage reports on "a high-powered breakfast meeting that took place in Washington, D.C., on 18 April," which "brought together leaders in the response to AIDS with members of the United States Congress, the administration, the private sector and AIDS advocates to emphasize how the adoption of the 'shared responsibility' approach is translating joint efforts into real results."

23 Apr 2013

Researchers urge doctors to consider Lyme disease as cause when presented with skin lesions

When a person contracts Lyme disease, quick diagnosis and treatment are essential to avoiding long term complications. But the diagnostic process may be delayed if a physician does not recognize a skin rash caused by Lyme disease because it does not have the bull's-eye appearance that is best known to physicians and the public.

23 Apr 2013

Global Fund working to fight malaria in Latin America

In the ONE blog, Deborah Derrick, president of Friends of the Global Fight Against AIDS, Tuberculosis and Malaria, writes about how the Global Fund to Fight AIDS, Tuberculosis and Malaria is working to prevent malaria in Latin America.

23 Apr 2013

ViroPharma announces results of VP20621 Phase 2 study for preventing recurrent CDI

ViroPharma Incorporated, an international biopharmaceutical company committed to developing and commercializing innovative products that address unmet medical needs and rare diseases, today announced the results of a Phase 2 study of VP20621 (non-toxigenic Clostridium difficile; NTCD) a novel treatment approach for preventing recurrent C. difficile infections.

23 Apr 2013

Merck, Bristol-Myers Squibb to evaluate daclatasvir and MK-5172 for treatment of HCV infection

Merck today announced it has entered into a non-exclusive agreement with Bristol-Myers Squibb to conduct a Phase II clinical trial to evaluate the safety and efficacy of a once-daily oral combination regimen consisting of Bristol-Myers Squibb's investigational NS5A replication complex inhibitor daclatasvir and Merck's investigational NS3/4A protease inhibitor MK-5172 for the treatment of chronic hepatitis C virus infection, genotype 1.

23 Apr 2013

DNAzymes, gold nanoparticles and disease detection: an interview with Dr Chan and Kyryl Zagorovsky, University of Toronto

Gold nanoparticles are tiny spherical particles made out of gold atoms with sizes on nanometre scale. This is around 1,000 times smaller than the thickness of human hair.

23 Apr 2013

Texas scientist says nonmedical community should be educated about long-term effects of antibiotic overuse and misuse

When thousands of experimental biology researchers gather in Boston this weekend, many of them undoubtedly will be presenting work related to the hunt for the next generation of antibiotics and how to battle back existing and emerging superbugs.

22 Apr 2013

Vaginal infections can be treated and prevented using Cranberry-Active tablets

Dutch Medical Brands receives first European Class IIa Medical Device Status to treat vaginal infections by using cranberry extracts.

22 Apr 2013

Time dwindling to meet IDSA goal of 10 new antibiotics by 2020

Despite the desperate need for new antibiotics to combat increasingly deadly resistant bacteria, the U.S. Food and Drug Administration (FDA) has approved only one new systemic antibiotic since the Infectious Diseases Society of America (IDSA) launched its 10 x '20 Initiative in 2010 - and that drug was approved two and a half years ago.

22 Apr 2013

TEDMED conference speaker highlights key actions to stop pandemics

Some 2,000 health professionals and thought leaders from all sectors of society are attending TEDMED at the Kennedy Center [in Washington, D.C.,] this week for a series of talks [focusing on medical technology and health care], which are also being televised in more than 80 countries.

22 Apr 2013

Edible malarial vaccine may work against other viral and bacterial infections

Can scientists rid malaria from the Third World by simply feeding algae genetically engineered with a vaccine? That's the question biologists at UC San Diego sought to answer after they demonstrated last May that algae can be engineered to produce a vaccine that blocks malaria transmission.

22 Apr 2013

Disease/Infection News

Gilead Sciences to present results from four Phase 3 clinical trials at International Liver Congress 2013

GeneCapture developing new device with one-hour pathogen testing capabilities

U.S. Supreme Court to hear oral arguments to decide fate of anti-prostitution pledge

Highly active ART does not appear to impair heart function, study suggests

Partnership and accountability among countries will lead to global health successes

Number of H7N9 cases surpasses 100; U.S. CDC warns physicians to be vigilant

U.S. leaders, AIDS activists gather in Washington to discuss 'shared responsibility' in tackling disease

Researchers urge doctors to consider Lyme disease as cause when presented with skin lesions

Global Fund working to fight malaria in Latin America

ViroPharma announces results of VP20621 Phase 2 study for preventing recurrent CDI

Merck, Bristol-Myers Squibb to evaluate daclatasvir and MK-5172 for treatment of HCV infection

DNAzymes, gold nanoparticles and disease detection: an interview with Dr Chan and Kyryl Zagorovsky, University of Toronto

Texas scientist says nonmedical community should be educated about long-term effects of antibiotic overuse and misuse

Vaginal infections can be treated and prevented using Cranberry-Active tablets

Time dwindling to meet IDSA goal of 10 new antibiotics by 2020

TEDMED conference speaker highlights key actions to stop pandemics

Edible malarial vaccine may work against other viral and bacterial infections

Penn researcher wins Distinguished Clinical Research Achievement Award for innovations in gene therapy

Sleep related breathing disorders associated with cognitive and behavioral impairment in children

Donors must 'seize this opportunity' to fully support the Global Fund

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Latest News